These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21882774)

  • 1. Deployment-related testing and treatment for latent tuberculosis infection, Part I.
    Mancuso JD; Keep LW
    Mil Med; 2011 Aug; 176(8):865-9. PubMed ID: 21882774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deployment-related testing and treatment for latent tuberculosis infection, part II.
    Mancuso JD; Keep LW
    Mil Med; 2011 Oct; 176(10):1088-92. PubMed ID: 22128639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis as a force health protection threat to the United States military.
    Sanchez JL; Sanchez JL; Cooper MJ; Hiser MJ; Mancuso JD
    Mil Med; 2015 Mar; 180(3):276-84. PubMed ID: 25735017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief report: number of tuberculosis tests and diagnoses of latent tuberculosis infection in active component service members, U.S. Armed Forces, January 2004-December 2014.
    Armed Forces Health Surveillance Center (AFHSC)
    MSMR; 2014 Dec; 21(12):8-10; discussion 9-10. PubMed ID: 25555209
    [No Abstract]   [Full Text] [Related]  

  • 5. Latent TB Infection in USSOF: A Refresher and Update.
    Tang SH; Evans JD; Vostal A; Shishido AA
    J Spec Oper Med; 2021; 21(4):108-111. PubMed ID: 34969139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active tuberculosis and recent overseas deployment in the U.S. Military.
    Nevin RL
    Am J Prev Med; 2010 Dec; 39(6):e39-40; author reply e40. PubMed ID: 21084066
    [No Abstract]   [Full Text] [Related]  

  • 7. Development and implementation of a cohort review for latent TB infection.
    Mancuso JD; Aaron CL
    Chest; 2015 Jan; 147(1):e25-e26. PubMed ID: 25560872
    [No Abstract]   [Full Text] [Related]  

  • 8. Identifying Priorities for Testing and Treatment of Latent Tuberculosis Infection in the United States.
    Martinez L; Andrews JR
    Clin Infect Dis; 2021 Nov; 73(9):e3483-e3485. PubMed ID: 32588882
    [No Abstract]   [Full Text] [Related]  

  • 9. Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.
    LoBue PA; Mermin JH
    Lancet Infect Dis; 2017 Oct; 17(10):e327-e333. PubMed ID: 28495525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in Obtaining Estimates of the Risk of Tuberculosis Infection During Overseas Deployment.
    Mancuso JD; Geurts M
    Am J Trop Med Hyg; 2015 Dec; 93(6):1172-8. PubMed ID: 26416114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis trends in the U.S. Armed Forces, active component, 1998-2012.
    Mancuso JD; Aaron CL
    MSMR; 2013 May; 20(5):4-8. PubMed ID: 23731007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis and the military.
    O'Shea MK; Wilson D
    J R Army Med Corps; 2013 Sep; 159(3):190-9. PubMed ID: 24109141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards better management of latent tuberculosis infection in children and young adults in the Maghreb. Conclusions of an expert meeting, Paris, 16 March 2018.
    Delacourt C; Zellweger JP;
    Arch Pediatr; 2019 Feb; 26(2):126-129. PubMed ID: 30642745
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence, screening and treatment of latent tuberculosis among oral corticosteroid recipients.
    Vozoris NT; Seemangal J; Batt J
    Eur Respir J; 2014 Nov; 44(5):1373-5. PubMed ID: 24969656
    [No Abstract]   [Full Text] [Related]  

  • 15. Cascade of Care in the Management of Latent Tuberculosis Infection in the United States: A Lot to Improve and to Scale Up.
    Wilson JW; Kissner DG; Escalante P
    Ann Am Thorac Soc; 2021 Oct; 18(10):1620-1621. PubMed ID: 34596496
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study.
    Gao L; Li X; Liu J; Wang X; Lu W; Bai L; Xin H; Zhang H; Li H; Zhang Z; Ma Y; Li M; Feng B; Du J; Sui H; Zhao R; Su H; Pan S; Guan L; Shen F; He J; Yang S; Si H; Cheng X; Xu Z; Tan Y; Chen T; Xu W; Peng H; Wang Z; Zhu T; Chen X; Zhou X; Guan X; Jin Q;
    Lancet Infect Dis; 2017 Oct; 17(10):1053-1061. PubMed ID: 28716677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current approach to latent tuberculosis diagnosis and treatment among medical center occupational health physicians.
    Vinnard C; Linkin D; Behrman A
    Infect Control Hosp Epidemiol; 2012 Dec; 33(12):1262-5. PubMed ID: 23143368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States.
    Reves R; Daley CL
    JAMA Intern Med; 2016 Oct; 176(10):1439-1440. PubMed ID: 27599130
    [No Abstract]   [Full Text] [Related]  

  • 19. [Latent tuberculosis infection screening in healthcare workers in four large hospitals in Santiago, Chile].
    Hernández M; Casar C; García P; Morales V; Mamani N; Gómez-Cofré N; Pizarro P; Balcells ME
    Rev Chilena Infectol; 2014 Jun; 31(3):254-60. PubMed ID: 25146198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Rifapentine and Isoniazid Directly Observed Therapy for the Treatment of Latent Tuberculosis Infection in a Military Clinic.
    Jinbo J; Lustik M; West GF; Kloetzel M
    Mil Med; 2017 Sep; 182(9):e2024-e2029. PubMed ID: 28885972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.